Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2017

View Archived Issues

Dendright extends collaboration with Janssen and adds Arthritis Queensland as a partner

Eisai, Chugai and Roche sign agreements for flunitrazepam rights in Japan

Telix and Wilex sign license agreement for Redectane

Bristol-Myers Squibb patents IRAK-4 inhibitors

Sumitomo Dainippon Pharma report compounds for treatment of cancer

European Commission confirms orphan drug designation for TB-403 for medulloblastoma

Team in Portugal describes antimalarial agents

AnaMar reports 5-HT2B receptor antagonists

GlaxoSmithKline patents EZH2 inhibitors for cancer

Pierre Fabre reports Plk-1 inhibitors

177Lu-PSMA-617 demonstrates favorable safety and high efficacy in patients with mCRPC

Results from second pivotal trial of ulipristal acetate for abnormal uterine bleeding

Bivalent Vaxwave vaccine shows in vivo efficacy in models of cytomegalovirus infection

Evotec and MaRS Innovation announce launch of Fibrocor Therapeutics

NRC supports Fedora's development of antimicrobial product candidates

AstraZeneca updates status of durvalumab trials in first-line NSCLC

FDA designates NS-065 an orphan drug for the treatment of Duchenne muscular dystrophy

Horizon Discovery broadens gene-editing capabilities

Audentes Therapeutics gives update on programs at J.P. Morgan meeting

Novogene to acquire Pacific Biosciences' Sequel Systems

CytomX initiates first-in-human study of CX-072 to treat solid tumors and lymphomas

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...